|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cortés-Sempere M and Ibáñez de Cáceres I:
microRNAs as novel epigenetic biomarkers for human cancer. Clin
Transl Oncol. 13:357–362. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sreekumar R, Sayan BS, Mirnezami AH and
Sayan AE: MicroRNA control of invasion and metastasis pathways.
Front Genet. 2:582011. View Article : Google Scholar
|
|
4
|
Shi KQ, Lin Z, Chen XJ, Song M, Wang YQ,
Cai YJ, Yang NB, Zheng MH, Dong JZ, Zhang L, et al: Hepatocellular
carcinoma associated microRNA expression signature: Integrated
bioinformatics analysis, experimental validation and clinical
significance. Oncotarget. 6:25093–25108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Z, Yu X, Shen J, Wu WK and Chan MT:
MicroRNA expression and its clinical implications in Ewing's
sarcoma. Cell Prolif. 48:1–6. 2015. View Article : Google Scholar
|
|
6
|
Lee HK, Finniss S, Cazacu S, Bucris E,
Ziv-Av A, Xiang C, Bobbitt K, Rempel SA, Hasselbach L, Mikkelsen T,
et al: Mesenchymal stem cells deliver synthetic microRNA mimics to
glioma cells and glioma stem cells and inhibit their cell migration
and self-renewal. Oncotarget. 4:346–361. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pichler M and Calin GA: MicroRNAs in
cancer: From developmental genes in worms to their clinical
application in patients. Br J Cancer. 113:569–573. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang W, Zhang E and Lin C: MicroRNAs in
tumor angiogenesis. Life Sci. 136:28–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kohlhapp FJ, Mitra AK, Lengyel E and Peter
ME: MicroRNAs as mediators and communicators between cancer cells
and the tumor microenvironment. Oncogene. 34:5857–5868. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao D, Jia P, Wang W and Zhang G:
VEGF-mediated suppression of cell proliferation and invasion by
miR-410 in osteosarcoma. Mol Cell Biochem. 400:87–95. 2015.
View Article : Google Scholar
|
|
13
|
Wang Y, Fu J, Jiang M, Zhang X, Cheng L,
Xu X, Fan Z, Zhang J, Ye Q and Song H: miR-410 is overexpressed in
liver and colorectal tumors and enhances tumor cell growth by
silencing FHL1 via a direct/indirect mechanism. PLoS One.
9:e1087082014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen L, Zhang J, Feng Y, Li R, Sun X, Du
W, Piao X, Wang H, Yang D, Sun Y, et al: miR-410 regulates MET to
influence the proliferation and invasion of glioma. Int J Biochem
Cell Biol. 44:1711–1717. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li D, Yang Y, Zhu G, Liu X, Zhao M, Li X
and Yang Q: MicroRNA-410 promotes cell proliferation by targeting
BRD7 in non-small cell lung cancer. FEBS Lett. 589:2218–2223. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo R, Gu J, Zhang Z, Wang Y and Gu C:
MicroRNA-410 functions as a tumor suppressor by targeting
angiotensin II type 1 receptor in pancreatic cancer. IUBMB Life.
67:42–53. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shen J, Niu W, Zhou M and Zhang H, Ma J,
Wang L and Zhang H: MicroRNA-410 suppresses migration and invasion
by targeting MDM2 in gastric cancer. PLoS One. 9:e1045102014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen N, Wang J, Hu Y, Cui B, Li W, Xu G,
Liu L and Liu S: MicroRNA-410 reduces the expression of vascular
endothelial growth factor and inhibits oxygen-induced retinal
neovascularization. PLoS One. 9:e956652014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Müssnich P, Raverot G, Jaffrain-Rea ML,
Fraggetta F, Wierinckx A, Trouillas J, Fusco A and D'Angelo D:
Downregulation of miR-410 targeting the cyclin B1 gene plays a role
in pituitary gonadotroph tumors. Cell Cycle. 14:2590–2597. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu Y, Zhao Y, Sun XH, Ge J, Zhang B, Wang
X and Cao XC: Down-regulation of miR-129-5p via the Twist1-Snail
feedback loop stimulates the epithelial-mesenchymal transition and
is associated with poor prognosis in breast cancer. Oncotarget.
6:34423–34436. 2015.PubMed/NCBI
|
|
21
|
Yu X and Li Z: MicroRNA expression and its
implications for diagnosis and therapy of tongue squamous cell
carcinoma. J Cell Mol Med. 20:10–16. 2016. View Article : Google Scholar
|
|
22
|
Li Z, Yu X, Shen J, Law PT, Chan MT and Wu
WK: MicroRNA expression and its implications for diagnosis and
therapy of gallbladder cancer. Oncotarget. 6:13914–13921. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu X and Li Z: The role of microRNAs
expression in laryngeal cancer. Oncotarget. 6:23297–23305. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Takahashi RU, Miyazaki H and Ochiya T: The
roles of microRNAs in breast cancer. Cancers (Basel). 7:598–616.
2015. View Article : Google Scholar
|
|
25
|
Goh JN, Loo SY, Datta A, Siveen KS, Yap
WN, Cai W, Shin EM, Wang C, Kim JE, Chan M, et al: microRNAs in
breast cancer: Regulatory roles governing the hallmarks of cancer.
Biol Rev Camb Philos Soc. Jan 28–2015.Epub ahead of print.
PubMed/NCBI
|
|
26
|
Bracken CP, Khew-Goodall Y and Goodall GJ:
Network-based approaches to understand the roles of miR-200 and
other microRNAs in cancer. Cancer Res. 75:2594–2599. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang J, Zhang SY, Gao YM, Liu YF, Liu YB,
Zhao ZG and Yang K: MicroRNAs as oncogenes or tumour suppressors in
oesophageal cancer: Potential biomarkers and therapeutic targets.
Cell Prolif. 47:277–286. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gattolliat CH, Thomas L, Ciafrè SA,
Meurice G, Le Teuff G, Job B, Richon C, Combaret V, Dessen P,
Valteau-Couanet D, et al: Expression of miR-487b and miR-410
encoded by 14q32.31 locus is a prognostic marker in neuroblastoma.
Br J Cancer. 105:1352–1361. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kotiyal S and Bhattacharya S: Breast
cancer stem cells, EMT and therapeutic targets. Biochem Biophys Res
Commun. 453:112–116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Saitoh M: Epithelial-mesenchymal
transition is regulated at post-transcriptional levels by
transforming growth factor-β signaling during tumor progression.
Cancer Sci. 106:481–488. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kwon CH, Park HJ, Choi JH, Lee JR, Kim HK,
Jo HJ, Kim HS, Oh N, Song GA and Park Y: Snail and serpinA1 promote
tumor progression and predict prognosis in colorectal cancer.
Oncotarget. 6:20312–20326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cho HJ, Park SM, Kim IK, Nam IK, Baek KE,
Im MJ, Yoo JM, Park SH, Ryu KJ, Han HT, et al: RhoGDI2 promotes
epithelial-mesenchymal transition via induction of Snail in gastric
cancer cells. Oncotarget. 5:1554–1564. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cichon MA and Radisky DC: ROS-induced
epithelial-mesenchymal transition in mammary epithelial cells is
mediated by NF-κB-dependent activation of Snail. Oncotarget.
5:2827–2838. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pilli VS, Gupta K, Kotha BP and Aradhyam
GK: Snail-mediated Cripto-1 repression regulates the cell cycle and
epithelial-mesenchymal transition-related gene expression. FEBS
Lett. 589:1249–1256. 2015. View Article : Google Scholar : PubMed/NCBI
|
